This inventor holds 2 USPTO granted patents. Top assignee: The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2011-2012.
Company Filing History:
Years Active: 2011-2012
Title: Innovations by Geoffrey W. Patton in Renal Cancer Treatment
Introduction
Geoffrey W. Patton is an accomplished inventor based in Wheaton, MD (US). He has made significant contributions to the field of medical treatments, particularly in the area of renal cancer. With a total of 2 patents, his work focuses on innovative methods for treating this serious condition.
Latest Patents
Patton's latest patents include groundbreaking methods for treating renal cancer using 4-[bis[2-[(methylsulfonyl)oxy]ethyl]amino]-benzaldehyde. The first patent outlines methods of treating a mammalian subject with renal cancer through the administration of this compound. It also details administration protocols and dosing schedules suitable for patients undergoing treatment. The second patent similarly features the use of 4-[bis[2-[(methylsulfonyl)oxy]ethyl]amino]-benzaldehyde, emphasizing the importance of pharmaceutical compositions in effective treatment methods.
Career Highlights
Geoffrey W. Patton works for the United States of America, as represented by the Secretary, Department of Health and Human Services. His role in this esteemed organization highlights his commitment to advancing healthcare solutions and improving patient outcomes.
Collaborations
Patton has collaborated with notable colleagues, including Susan Elaine Bates and Rao Vishnuvajjalla. These partnerships have likely contributed to the development and refinement of his innovative treatment methods.
Conclusion
Geoffrey W. Patton's contributions to renal cancer treatment through his patents demonstrate his dedication to medical innovation. His work not only reflects his expertise but also has the potential to significantly impact patient care in the field of oncology.